跳至主要内容
临床试验/EUCTR2013-003478-29-ES
EUCTR2013-003478-29-ES进行中(未招募)不适用

The effect on quality of life of Vitamin D administration for advanced cancer treatment. A randomized controlled trial - VIDAFACT

Maria Nabal Vicuña (Paliative Care Supportive Team-Hospital Universitari Arnau de Vilanova de Lleida)0 个研究点开始时间: 2013年10月8日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients satisfying inclusion criteria will be randomly assigned to receive vitamin D or placebo. Eligible patients
  • will be adults (18 years or older) having a locally advanced or metastatic or inoperable solid cancer under palliative care,
  • upon signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 274
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria will be having a Karnofsky < 30%, being pregnant or breast-feeding
  • females, undergoing severe liver or renal (GRF<60) failure, having a cognitive deterioration (more than 5 mistakes in
  • Pfeiffer test)., suffering from significant (more than 6 out of 10 in a Numerical Rating Scale 0:10) pain, dyspnea, nausea or
  • vomits, or having received chemo or radiation therapy within the last 3 weeks prior to inclusion, or with the possibility of
  • iniciating a new cycle of chemo or radiation therapy within a period of 6 weeks after their inclusion date.

研究者

发起方
Maria Nabal Vicuña (Paliative Care Supportive Team-Hospital Universitari Arnau de Vilanova de Lleida)

相似试验

The effect on quality of life of Vitamin D... | 临床试验